A Reading-based firm that intends to associate with the Lake Erie College of Osteopathic Medicine on medical marijuana study will reapply for a license from the Pennsylvania Department of Public Health following its first application was refused.
The Pennsylvania Department of Health refused the software of eight candidates who hunted growing/processing and dispensary licenses within their nation’s medical marijuana research plan. One of the candidates was Franklin Labs, which has partnered with all the Erie medical institution to conduct the study.
“They’re frustrated,” LECOM spokesman Pierre Bellicini stated in a brief statement after speaking with Franklin Labs officials. “Franklin Labs is working on another step and thLey intend to use .”
The health division rejected Franklin Labs’ application as it failed to incorporate a legal contractual relationship with an academic research center, according to a letter that the health department delivered Tuesday to Franklin Labs CEO Berchard Suber.
Franklin Labs’ contract with LECOM was considered invalid because it had been signed prior to the medical school was licensed as an academic clinical research center in the nation’s medical marijuana program. LECOM was certified in May.
Two other candidates were rejected for the identical reason. Others have been rejected for failing to incorporate a dispensary program and required fees, for failing to meet minimal program scores or for not following instructions, philly.com documented.
“Our purpose is to make sure that our study program works at the greatest standards,” Pennsylvania Health Secretary Rachel Levine, M.D., stated in a news release. “We’re disappointed that awards weren’t made, but have to uphold the criteria set out in regulations.”
The study plan is part of Pennsylvania’s Medical Marijuana Law and has been revised, following a Commonwealth Court judge issued a preliminary injunction in May, to need medical department endorsement of the firms with whom every college spouses, philly.com registered.
State officials said the application could place Pennsylvania one of the leaders in medical marijuana study but present licensees have stated they stress it is just another way providers can secure licenses without moving through the rigorous application procedure they did.
Every firm that receives a license could grow bud and start as many as six dispensaries in the nation.
“We are all responsible for the medical investigation. But this does not look like medical investigation as far as a mechanism for organizations to bypass the software process we failed,” GTI CEO Pete Kadens stated earlier this season.
GTI owns and works Rise Erie, Erie’s sole legal medical marijuana dispensary.
A group of farmers and dispensary operators at Pennsylvania filed a suit Nov. 27 from the health area. The team, called Medical Marijuana Advocates for Research, stated they consider the law’s developments concerning the research plan still do not create the vetting procedure transparent enough.